4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-18-001011
Executive Vice President R&D gave up 53,117 shares (to pay taxes)
- Executive Vice President R&D acquired 116,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LEBEL FRANCOIS Executive Vice President R&D | 2017-12-29 | Grant or award | +116,000 | 253,683 | D | ||
| LEBEL FRANCOIS Executive Vice President R&D | 2017-12-30 | Shares withheld for taxes | −31,450 | $4.14 | $130,203 | 222,233 | D |
| LEBEL FRANCOIS Executive Vice President R&D | 2017-12-31 | Shares withheld for taxes | −21,667 | $4.14 | $89,701 | 200,566 | D |
Loading xslF345X03/doc4.xml…